| |
|
|
|
| |
Outsourcing & Vaccines
All signs point to growth for vaccine services
Contract Pharma – November/December 2009
During the past decade, a number of major pharma companies entered the vaccine market, growing through internal investment or acquisition. At the same time, we’ve seen a burst of vaccine-focused biotech startups. The surge of interest in this field is no surprise; according to a report from Scientia Advisors, worldwide sales of vaccines are expected to rise from $16 billion in 2007 to $35 billion in 2014. (This covers both prophylactic and therapeutic vaccines.) It’s also been a decade of panic; from biodefense to SARS to avian flu and now the swine flu pandemic, there’s been a seismic shift in vaccine funding this decade...Read the full article.
|
|
Vaccines, vaccine development, vaccine testing, Contract Pharma, prophylactic, therapeutic vaccines, influenza vaccine, inactivated/attenuated microorganisms, recombinant antigens, native antigens, novel delivery methods
Outsourcing & Vaccines: All signs point to growth for vaccine services | Contract Pharma
During the past decade, a number of major pharma companies entered the vaccine market, growing through internal investment or acquisition. At the same time, we’ve seen a burst of vaccine-focused biotech startups.